Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Distributing De Novo Software

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Molecular Devices will distribute De Novo Software's FCS Express 4 software under a licensing agreement announced today.

Under the terms of the deal, Molecular Devices will distribute the software to customers in the research and pharmaceutical markets worldwide. Further terms of the deal were not disclosed.

In FCS Express 4, analytical tools for flow and image cytometry and high-content screening are combined in one environment with report generation and online collaboration tools, the companies said. The software, which was launched by De Novo in January, adds the ability to access and interactively perform population-based analysis, while linking back to the individual images underlying the data.

"This enables highlighting of individual cells in an image from selected populations or display of single cells of interest in separate cell galleries," Molecular Devices and De Novo said in a joint statement. The tools improve assay development and workflow and enable rapid report generation, they added.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more